Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adrenal Gland Pheochromocytoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04187404
What this trial is testing

A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma

Who this might be right for
Adrenocortical CarcinomaPheochromocytomaParaganglioma
Enterome 70
Not applicableEnded earlyNCT03986593
What this trial is testing

Cryoablation of Bone Metastases From Endocrine Tumors

Who this might be right for
Neoplasm MetastasisThyroid NeoplasmPheochromocytoma+3 more
Instituto do Cancer do Estado de São Paulo 17
Early research (Phase 1)WithdrawnNCT01941849
What this trial is testing

Phase I Trial of Vandetanib Combined With 131I-mIBG to Treat Patients With Advanced Phaeochromocytoma and Paraganglioma

Who this might be right for
PhaeochromocytomaParaganglioma
University College, London
Not applicableStudy completedNCT00970970
What this trial is testing

Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease

Who this might be right for
Von Hippel-Lindau DiseaseHemangioblastomaRenal Cell Carcinoma+2 more
University Medical Center Groningen 22
Not applicableStudy completedNCT07339241
What this trial is testing

Abdominal Circumference as a Predictor of Operative Time in Retroperitoneal Adrenalectomy for Pheochromocytoma

Who this might be right for
Pheochromocytoma Malignant
Asan Medical Center 159
Testing effectiveness (Phase 2)Ended earlyNCT03165721
What this trial is testing

A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer

Who this might be right for
ParagangliomaGastrointestinal Stromal TumorsCarcinoma, Renal Cell+2 more
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT02721732
What this trial is testing

Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

Who this might be right for
Advanced Malignant Solid NeoplasmCarcinoma of Unknown PrimaryMetastatic Adrenal Gland Pheochromocytoma+16 more
M.D. Anderson Cancer Center 157
Testing effectiveness (Phase 2)Study completedNCT00458952
What this trial is testing

Phase 1 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma

Who this might be right for
PheochromocytomaParaganglioma
Molecular Insight Pharmaceuticals, Inc. 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT03946527
What this trial is testing

LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA)

Who this might be right for
ParagangliomaPheochromocytoma
Antonio Fojo 10
Testing effectiveness (Phase 2)Ended earlyNCT00466856
What this trial is testing

Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors

Who this might be right for
Head and Neck CancerIslet Cell TumorMetastatic Cancer+1 more
Vanderbilt-Ingram Cancer Center 10
Testing effectiveness (Phase 2)Study completedNCT03034200
What this trial is testing

Phase 2 Study of ONC201 in Neuroendocrine Tumors

Who this might be right for
Recurrent Neuroendocrine TumorMetastatic Neuroendocrine Tumor
Peter Anderson 30
Early research (Phase 1)Study completedNCT00339131
What this trial is testing

ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic Carcinoid

Who this might be right for
PheochromocytomaParagangliomaCarcinoid
Molecular Insight Pharmaceuticals, Inc. 24
Not applicableAvailableNCT03015844
What this trial is testing

A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma

Who this might be right for
NeuroblastomaPheochromocytoma
Northwell Health
Not applicableNo Longer AvailableNCT02431715
What this trial is testing

18F-FDOPA PET in Neuroendocrine Tumours

Who this might be right for
Thyroid Cancer, MedullaryCarcinoid TumorPheochromocytoma+3 more
British Columbia Cancer Agency
Testing effectiveness (Phase 2)Study completedNCT01152827
What this trial is testing

RAD001 in Pheochromocytoma or Nonfunctioning Carcinoid

Who this might be right for
PheochromocytomaExtra-adrenal ParagangliomaNon-functioning Carcinoid
Seoul National University Hospital 33
Testing effectiveness (Phase 2)Looking for participantsNCT05944237
What this trial is testing

HTL0039732 in Participants With Advanced Solid Tumours

Who this might be right for
NeoplasmsProstatic Neoplasms, Castration-ResistantStomach Neoplasms+11 more
Cancer Research UK 150
Early research (Phase 1)Study completedNCT00005860
What this trial is testing

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06503146
What this trial is testing

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

Who this might be right for
SarcomaSmall Cell Lung Cancer or Extrapulmonary Neuroendocrine Cancer (EP-NEC)Mesothelioma+7 more
National Cancer Institute (NCI) 320
Testing effectiveness (Phase 2)Looking for participantsNCT06427798
What this trial is testing

Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy

Who this might be right for
Somatostatin Receptor PositiveGastrointestinal Neuroendocrine TumorsPheochromocytoma+1 more
National Cancer Institute (NCI) 66
Not applicableEnrolling By InvitationNCT07316075
What this trial is testing

Multicenter Study on Cardiovascular and Metabolic Complications in Patients With Biochemically Silent Pheochromocytomas and Paragangliomas

Who this might be right for
Cardiovascular AbnormalitiesArterial Blood PressureHeart Rate+6 more
Laikο General Hospital, Athens 50
Next Page